New insights on diagnosis tools after renal transplantation;Nouveaux outils en transplantation rénale

Nephrologie et Therapeutique

Volumn 2, Issue 4, 2006, Pages 165-175

  Thervet, Éric ^a   Legendre, Christophe ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Acute rejection; Genotyping; Immunosuppressive treatment; Proteomic; Renal transplantation; Transcriptomic

Indexed keywords

ALLOANTIBODY; IMMUNOSUPPRESSIVE AGENT; TETRAMER; TRANSCRIPTOME; CYTOKINE; HLA ANTIGEN;

ANTIGEN SPECIFICITY; CELL DIVISION; DIAGNOSTIC TEST; DNA MICROARRAY; ENZYME LINKED IMMUNOSPOT ASSAY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMMUNE RESPONSE; KIDNEY TRANSPLANTATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT SURVEY; T LYMPHOCYTE; BIOPSY; CHRONIC KIDNEY FAILURE; GENETICS; GRAFT REJECTION; IMMUNOLOGY; LYMPHOCYTE; METHODOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY;

BIOPSY; CYTOKINES; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LYMPHOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 33748316539     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2006.04.008     Document Type: Short Survey

References (45)

1. Terasaki P.I. Humoral theory of transplantation. Am. J. Transplant. 3 6 (2003) 665
2. Duquesnoy R.J., Howe J., and Takemoto S. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients. Transplantation 75 6 (2003) 889
3. Anglicheau D., Legendre C., and Thervet E. Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives. Transplantation 78 3 (2004) 311
4. Thervet E., Legendre C., Beaune P., and Anglicheau D. Cytochrome P450 3A polymorphisms and immunosuppressive drugs. Pharmacogenomics 6 1 (2005) 37
5. Hesselink D.A., van Schaik R.H., van der Heiden I.P., et al. Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus. Clin. Pharmacol. Ther. 74 3 (2003) 245
6. Kuehl P., Zhang J., Lin Y., et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat. Genet. 27 4 (2001) 383
7. Thervet E., Anglicheau D., King B., et al. Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients. Transplantation 76 8 (2003) 1233
8. Anglicheau D., Verstuyft C., Laurent-Puig P., et al. Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients. J. Am. Soc. Nephrol. 14 7 (2003) 1889
9. Hoffmann S., Park J., Jacobson L.M., et al. Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int. 66 4 (2004) 1686
10. Rush D.N., Henry S.F., Jeffery J.R., Schroeder T.J., and Gough J. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 57 2 (1994) 208
11. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Allen R.D., and Chapman J.R. The natural history of chronic allograft nephropathy. N. Engl. J. Med. 349 24 (2003) 2326
12. Grebe S.O., and Mueller T.F. Immune monitoring in organ transplantation using neopterin. Curr. Drug Metab. 3 2 (2002) 189
13. Li B., Hartono C., Ding R., et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N. Engl. J. Med. 344 13 (2001) 947
14. Peng J., and Gygi S.P. Proteomics: the move to mixtures. J. Mass Spectrom. 36 10 (2001) 1083
15. Schaub S., Rush D., Wilkins J., et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J. Am. Soc. Nephrol. 15 1 (2004) 219
16. O'Riordan E., Orlova T.N., Mei J.J., et al. Bio-informatics analysis of the urine proteome of acute allograft rejection. J. Am. Soc. Nephrol. 15 12 (2004) 3240
17. Clarke W., Silverman B.C., Zhang Z., Chan D.W., Klein A.S., and Molmenti E.P. Characterization of renal allograft rejection by urinary proteomic analysis. Ann. Surg. 237 5 (2003) 660
18. Racusen L.C., Solez K., Colvin R.B., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 55 2 (1999) 713
19. Furness P.N., and Taub N. International variation in the interpretation of renal transplant biopsies: report of the CERTPAP Project. Kidney Int. 60 5 (2001) 1998
20. Yano N., Endoh M., Fadden K., et al. Comprehensive gene expression profile of the adult human renal cortex: analysis by cDNA array hybridization. Kidney Int. 57 4 (2000) 1452
21. Mansfield E.S., and Sarwal M.M. Arraying the orchestration of allograft pathology. Am. J. Transplant. 4 6 (2004) 853
22. Sarwal M., Chua M.S., Kambham N., et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N. Engl. J. Med. 349 2 (2003) 125
23. Scherer A., Krause A., Walker J.R., Korn A., Niese D., and Raulf F. Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies. Transplantation 75 8 (2003) 1323
24. Hernandez-Fuentes M.P., Warrens A.N., and Lechler R.I. Immunologic monitoring. Immunol. Rev. 196 (2003) 247
25. McLean A. What goes around (in kidney transplant rejection) does not necessarily come around (in the blood). Am. J. Transplant. 3 9 (2003) 1045
26. Segall M., Noreen H., Edwins L., Haake R., Shu X.O., and Kersey J. Lack of correlation of MLC reactivity with acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation. Hum. Immunol. 49 1 (1996) 49
27. Strijbosch L.W., Buurman W.A., Does R.J., Zinken P.H., and Groenewegen G. Limiting dilution assays. Experimental design and statistical analysis. J. Immunol. Methods 97 1 (1987) 133
28. Orosz C.G., Adams P.W., and Ferguson R.M. Frequency of human alloantigen-reactive T lymphocytes. II. Method for limiting dilution analysis of alloantigen-reactive helper T cells in human peripheral blood. Transplantation 43 5 (1987) 718
29. Moretti L., Giuliodori L., Stramigioli S., Luchetti F., Baldi A., and Sparaventi G. Limiting dilution analysis of IL-2 producing cells: I. Studies of normal human peripheral blood. Haematologica 77 6 (1992) 463
30. Hornick P.I., Brookes P.A., Mason P.D., et al. Optimizing a limiting dilution culture system for quantifying the frequency of interleukin-2-producing alloreactive T helper lymphocytes. Transplantation 64 3 (1997) 472
31. Kaminski E., Hows J., Goldman J., and Batchelor R. Optimizing a limiting dilution culture system for quantifying frequencies of alloreactive cytotoxic T lymphocyte precursors. Cell. Immunol. 137 1 (1991) 88
32. Kelso A., and Macdonald H.R. Precursor frequency analysis of lymphokine-secreting alloreactive T lymphocytes. Dissociation of subsets producing interleukin 2, macrophage-activating factor, and granulocyte-macrophage colony-stimulating factor on the basis of Lyt-2 phenotype. J. Exp. Med. 156 5 (1982) 1366
33. Game D.S., Hernandez-Fuentes M.P., Chaudhry A.N., and Lechler R.I. CD4+CD25+ regulatory T cells do not significantly contribute to direct pathway hyporesponsiveness in stable renal transplant patients. J. Am. Soc. Nephrol. 14 6 (2003) 1652
34. Miyahira Y., Murata K., Rodriguez D., et al. Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J. Immunol. Methods 181 1 (1995) 45
35. Czerkinsky C., Andersson G., Ekre H.P., Nilsson L.A., Klareskog L., and Ouchterlony O. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J. Immunol. Methods 110 1 (1988) 29
36. Lyons A.B., and Parish C.R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171 1 (1994) 131
37. Wells A.D., Gudmundsdottir H., and Turka L.A. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100 12 (1997) 3173
38. Altman J.D., Moss P.A., Goulder P.J., et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 5284 (1996) 94
39. Reijonen H., Kwok W.W., and Nepom G.T. Detection of CD4+ autoreactive T cells in T1D using HLA class II tetramers. Ann. N. Y. Acad. Sci. 1005 (2003) 82
40. Kao K.J., Scornik J.C., and Small S.J. Enzyme-linked immunoassay for anti-HLA antibodies: an alternative to panel studies by lymphocytotoxicity. Transplantation 55 1 (1993) 192
41. Scornik J.C., Bray R.A., Pollack M.S., et al. Multicenter evaluation of the flow cytometry T-cell crossmatch: results from the American Society of Histocompatibility and Immunogenetics-College of American Pathologists proficiency testing program. Transplantation 63 10 (1997) 1440
42. Rebibou J.M., Chabod J., Bittencourt M.C., et al. Flow-PRA evaluation for antibody screening in patients awaiting kidney transplantation. Transplant. Proc. 32 8 (2000) 2745
43. Douillard P., Pannetier C., Josien R., et al. Donor-specific blood transfusion-induced tolerance in adult rats with a dominant TCR-Vbeta rearrangement in heart allografts. J. Immunol. 157 3 (1996) 1250
44. Brouard S., Dupont A., Giral M., et al. Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation. Am. J. Transplant. 5 2 (2005) 330
45. Flechner S.M., Kurian S.M., Head S.R., et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am. J. Transplant. 4 9 (2004) 1475